Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126.SZ) stock: key figures, P/E, revenue and dividend
Consumer Staples · Drug Retail · China · ISIN CNE1000054V3
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.23 bn CNY | 5.14 bn CNY |
| Gross profit | 1.04 bn CNY | 936.34 m CNY |
| Operating income | 209.39 m CNY | 109.52 m CNY |
| EBIT | 174.60 m CNY | -113.67 m CNY |
| Net income | 26.57 m CNY | -242.46 m CNY |
| Diluted EPS – continuing operations | 0.13 CNY | -1.18 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. engages in pharmaceutical manufacturing, distribution, retail, and research and development activities in China and Hong Kong. The company operates retail pharmacy services, including Direct-to-Patient specialty pharmacy operations covering medications for cancer treatment, antiviral therapies, and organ transplant procedures. It also serves as an emergency pharmaceutical storage provider and public health emergency supply contractor for Hunan Province. Additionally, the company provides pharmaceutical services, including patient health record management, chronic disease management, and a patient data management system. It manufactures pharmaceutical products. The company also operates a pharmaceutical wholesaling and distribution business across Hunan Province. Additionally, it operates a full-time specialized medical institution, conducts pharmaceutical research and development activities, and engages in regenerative medicine operations. The company offers Chinese patent medicines, chemical pharmaceuticals, medical devices, cleansing and care products, medicinal wines, and food products. It serves hospitals, medical institutions, institutional pharmacy clients, and individual patients. TAT KA WAI HONG Pharmaceutical Industry Group Co., Ltd. was formerly known as Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. and changed its name to Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. in September 2026. Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. was founded in 2002 and is based in Changsha, China.
More stocks
- Neuberger Berman IMF Inc (NBH)
- Modern Avenue Group Co Ltd (002656.SZ)
- Lavipharm S.A (LAVI.AT)
- Agencia Comercial Spirits Ltd Class A Ordinary Shares (AGCC)
- AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust (AIMIRT.BK)
- Diamond Food Indonesia PT (DMND.JK)
- Rex Concepts S.A. (REX.WA)
- Heilongjiang Interchina Water Treatment Co Ltd (600187.SS)
- Jumbo Interactive Ltd (JIN.AX)
- ACME UNITED CORP (ACU)
- Dave & Buster's Entertainment, Inc. (PLAY)
- China Metal Products Co Ltd (1532.TW)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.